Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Sale
Class A Common Stock
2023-12-14$9.00/sh−20,141$181,269→ 53,823 total
Footnotes (1)
- [F1]Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on June 21, 2023